Institutional Capital & Cannabis (IC3) West
Santa Monica, CA
April 27 - 28, 2020


The North American cannabis industry is undergoing a rapid evolution.  Medical use of cannabis is now legal in 33 states, while recreational use is legal in 11 states plus the District of Columbia.  Both recreational and medical cannabis have been legal in California for over a year now.  With sales of over $5 billion and tax revenue of $345 million, the largest legal cannabis market in the world is just getting started.
Market participants are hoping that 2020 will be a year of stability through regulatory clarity, development on license provision and supply chain efficiencies.
The eigth installment of the Institutional Capital & Cannabis Conference (IC3) will return to the epicenter of this movement - California. By some estimates, the second largest city in the U.S. is already home to a billion-dollar cannabis market.
Following on the heels of successful conferences in California, Miami, NYC and London, IC3 West will reconvene with the industry’s top experts to evaluate market progress, the headwinds faced and the many opportunities that remain in California. 
IMN is excited to continue our IC3 series of forums aimed at sophisticated investors seeking alternative asset classes and portfolio diversification.  This event was created specifically with the needs of the legacy institutional and accredited investor in mind, with panel discussions addressing the various vehicles for investment, due diligence best practice, impact investing and setting realistic ROI expectations for cannabis investments.

Who Should Attend
  • Family Offices
  • High Net Worth Investors
  • Wealth Managers
  • Private Bankers
  • Financial Advisors
  • Private Equity Funds
  • Venture Capital Funds
  • Asset Managers
  • REITs
  • Cannabis Companies
  • Law Firms
  • Accounting Firms
  • Consultants
  • Technology Companies
  • Trade Associations
  • Advocacy Groups

Conference Highlights

Networking Tutorial

    Platform Introduction


    Getting Started


    Updating Personal Info


    Updating Demographics


    Searching By Name/Company


    Filter By Demographics


    Send Invitation


    Accept Invitation


    Messaging Connections


    Post Conference Content


My Agenda

  • To view your agenda you must be signed in Sign-In


    Preliminary Agenda

      A Pivotal Year for Cannabis: Breaking Down the Numbers

      • 2020 is gearing up to be a pivotal year for the cannabis industry.  The start of the year saw the first recreational sales in Illinois, and neighbors New York and New Jersey, amongst others, have plans in place to advance their legalization efforts.  The launch of ‘Cannabis 2.0’ in Canada will be closely monitored as provincial and local programs work out teething issues to align supply with demand.  This opening presentation will take a look at the trends and drivers that can help investors and industry practitioners plan for the future.

      Investment Opportunities in Legal Cannabis

      • There are a number of investment sectors in the cannabis industry that attract attention from various capital vehicles.  Each sector is different from the other and has unique opportunities and challenges associated with it.  This opening panel will discuss how opportunities are evolving across these sectors and what investors should consider when making decisions.

      Legalization, Regulatory Changes and their Potential Impact on Cannabis Investment

      • Many investors do not understand the laws relating to cannabis and, therefore, find it difficult to make informed decisions about potential investments in the space.  This panel of legal experts and regulators will offer an open discussion on shifts in the regulatory environment at the local, state and federal level and what this means for potential investments in the space.

      Investing in People: Increase Diversity to Increase Returns

      • Investors, cannabis company executives and board members discuss the importance of gender, race and generational diversity within leadership teams.  Focus will be on why this makes sense from a business perspective and how it can lead to a closer relationship with the consumer.

      Building a Successful Cannabis Consumer Brand

      • Vertically integrated operators are fairly well understood given this is the legacy framework, however there are many different approaches to building a successful consumer brand.  There are certain things that every business and investor needs to know and this session will address the importance of intellectual property (IP) and protection strategies, along with scaling and the major differences between businesses “touching the plant” and “not touching the plant”.

      Shaping the Future of Cannabis Through Research and Development

      • We are continuing to see an increasing number of people and organizations committed to research and development in the cannabis space.  Clinical research into the medical efficacy of cannabis is paramount in gaining acceptance from regulatory agencies like the FDA but other areas of research are also vital to the future of cost-effective production on a large scale.  These scientists and pioneers will discuss the work that is being done to achieve these goals and what changes are necessary to do so.

      Social Equity and the Societal Impact of Legal Cannabis

      • There is no one-size-fits all model when designing and implementing meaningful, lasting social equity provisions within state and local cannabis programs.  These advocates discuss the benefits that social equity programs can have for communities and industry stakeholders, while addressing the hurdles that are being faced around the country when it comes to writing and implementing these provisions.

      Due Diligence and Setting Realistic Expectations for Cannabis Investments

      • As is often the case with nascent industries, many people have unrealistic return expectations.  It is essential that teams deploying capital into the space – perhaps for the first time – properly understand this unique investment opportunity.  This group of active investors discuss some of the investments they have made across the spectrum of cannabis-related businesses, their ROIs, company valuations and their processes and best practices for due diligence pre-investment.

      Cannabis 2.0: Update on a New Canadian Market

      • Now that infused and other cannabis-derived products have hit shelves in Canada, we take the pulse of the market, look at new products and forecast what is next for Cannabis 2.0 in Canada, addressing implications for the US legal markets.

      Investment Strategies Involving Cannabis Real Estate

      • Industry demand for real estate is on the rise, opening up significant new opportunities for real estate investors and other industry professionals.  Cannabis cultivation, processing and retail operations require a lot space and finding innovative ways to make this space available is one of the real challenges facing the industry.  This panel of investors, landlords and tenants will discuss the opportunities and challenges associated with owning real estate used in the cannabis supply chain.  

      The California Opportunity

      • With changes expected this year to the California cannabis regulatory framework, this panel of operators, regulators and legal experts discuss the main challenges and opportunities for the legal market in California for the coming year and what they believe needs to be done to see the market thrive in the nation’s most populous state

      From Theory to Reality: Invest Like the Best

      • Following a day of education and discussion, this session pulls it all together, and we hear from experienced investors and finance professionals who are already active in this exciting new asset class. Our panelists reveal firsthand accounts of where they've found success, hard lessons learned and pitfalls to be avoided, and key nuggets of advice they have for those considering investing in this space.

      The Changing Face of Cannabis Investing

      • Legacy institutional investors and wealth managers have been entering the cannabis space in recent years and we are seeing many alternative investment vehicles gaining traction such as cannabis ETFs and SPACs.  These large funds, wealth managers and SPACs join us to discuss how they got into the space, what got them over the hump and how the level of buzz amongst their peers has changed in the past couple of years.

      The Role of Investors in Helping Cannabis Companies Get to the Next Level

      • So you’ve made a cannabis investment – now what?  This panel of investors will address the next steps for any investor looking to enter the cannabis space.  They will discuss what you, as an investor, can do to help the business grow including reporting, other processes and shaping company culture. 

      Update on Opportunities in Europe and Other International Markets

      • Europe is on track to become the world’s largest legal cannabis market within the next five years, with over €500million of investments into European cannabis companies in the last year and a forecasted market worth up to €123billion by 2028. Other markets such as Australia, Latin America, Thailand, South Korea and Israel are at different stages of legalizing marijuana either medicinally or recreationally and are attracting investments from US and Canadian cannabis companies and investors.  This session will address the many opportunities across a range of regions, while also discussing the challenges associated with different legal systems, patient access, cultivation supply, logistics and access to products such as oils.

      Sale Leasebacks & The Rising Use of Debt in Cannabis

      • Cannabis companies are increasingly using debt and sale leasebacks as a source of capital to fund growth and operational costs.  We discuss the pros and cons of this trend and how we see capital entering the space changing over the coming years.

      The Future of Cannabis ETFs

      Crystal Balling the Future of Cannabis

      • After one and a half days of discussion, where does this leave us?  Which prior predictions played out and what’s in store for the coming year?  Industry leaders from business and policy discuss federal legalization and the pathway to the end of prohibition.



To register for this conference you must be signed in

  • Investor Super Early Bird* - $395
  • Investor Early Bird* - $695
  • Investor Standard rate* - $995
  • Standard Super Early Bird - $995
  • Standard Early Bird - $1,495
  • Standard rate - $1,995
  • On-site rate - $2,095

Contact Us


  • Conference Venue
  • Fairmont Miramar Hotel & Bungalows

    101 Wilshire Boulevard
    Santa Monica, CA, 90401
    Fax: 310-458-7912

    Additional Info:

    Discounted rooms can be booked using the above reservation link.  All rooms are available on a first come first served basis until April 6, 2020. IMPORTANT: IMN has not retained a third party booking agent to assist with reservations.  All reservations for this conference must be made using the booking link above.

1120 Avenue of the Americas, 6th Floor, New York, NY 10036
Tel: +1(212)901-0506 Fax: +1(212)768-2484

View Full Site
You need to login before accessing this section. Click "Login" from bottom menu.

Please sign in

Create Account Recover Password Sign in with LinkedIn

Enter Your Email: